Where to buy Sarilumab

Sarilumab is approved to treat moderate to severe rheumatoid arthritis in adults. This is an option if previous treatments were not effective enough or well tolerated. There are many different rheumatic diseases, but rheumatoid arthritis is probably the most well-known. In this condition, several joints become permanently inflamed and, over time, may become deformed and stiff. Muscles also become weaker.

In advanced rheumatoid arthritis, joint stiffness can make daily tasks difficult. Other symptoms, such as pain and fatigue, are also a big concern. Various medications are used in the treatment of rheumatoid arthritis to relieve symptoms, reduce inflammation, and keep joints mobile for as long as possible. There are two main types of treatment, called disease-modifying therapy and allopathic therapy. Disease-modifying therapies are designed to stop the progression of rheumatoid arthritis. The patient is first given conventional disease-modifying anti-rheumatic drugs (DMARDs), such as methotrexate and others. If these drugs are no longer effective, they can be replaced with drugs produced by biotechnology (biopharmaceuticals or biologics). Salirumab is an antibody that can be used alone or in combination with methotrexate to reduce inflammation and relieve symptoms.

The patent drug of Salirutumab is a new type of drug for treating diseases. It is not yet on the market in China, and therefore it is not covered by medical insurance. Salirutumab The common dosage form of the original drug is injection, which has been marketed overseas. The European version of the specification200mg*2 per box is priced around 17,500 (The price may fluctuate due to the exchange rate). The purchase of the original drug of Salirutumab needs to be purchased through formal channels. There are currently no generic versions of Salirutumab produced in other countries.